Sort by
Refine Your Search
-
Country
-
Program
-
Field
-
stable open-source microscope for the community. You will work closely together with an electrical engineer who will be developing the instrument control software and electronics, and you will be part of a
-
range of scientific audiences. Eagerness to learn new techniques and to stay up to date with the current literature to inform experimental design. Expertise in managing collaborations and working in teams
-
using large-scale multi-omics approaches, organoid technology, as well as novel animal models. Qualifications and skills Applicants should hold a Ph.D. degree in Biomedical Sciences, Bioengineering
-
compatible with current technological integration. One optimization strategy is the fabrication of ultra-long, aligned polymers at interfaces and their decoration with molecular magnets. Recent work has
-
through research. It is a consortium that brings together a dozen European academic partners, in addition to private companies, coordinated by the CNRS in Bordeaux (F). Introduction to SigSynCell Current
-
positions based on performance and funding. Qualifications: A Ph.D. (or equivalent) in electrical engineering, biomedical engineering, computer science, medical physics, or a related field is required
-
, Electrical Engineering, Biomedical Engineering, Statistics, or a related field. Strong background in machine learning, data mining, statistical analysis, and computational modeling; Experience with programming
-
Group Leader at Católica Biomedical Research Centre and Assistant or Associate Professor at Católica
technologies that bridge medicine, data science, biology and engineering. CBR currently comprises about 60 researchers and is aiming to grow towards 150-200 researchers in next 5 years. Current CBR investigators
-
research. UM6P offers highly competitive incentives to its current and future talented research staff. About LIMSET LIMSET, the Laboratory of Inorganic Materials for Sustainable Energy Technologies, is
-
gain new insights into biological concepts and disease targets. We will combine advanced cellular and molecular techniques in immunology and neurobiology with genetic-engineering tools, quantitative